Bottom line
MBNE vs ESGD: the short answer
MBNE (State Street(R) Nuveen Municipal Bond ESG ETF) and ESGD (iShares ESG Aware MSCI EAFE ETF) are both etfs.
ESGD is cheaper at 0.2% vs 0.43% — a difference of $23 a year per $10,000 invested.
Over one year, ESGD returned +3.8% vs +1.7% for MBNE.
Updated Nov 19, 2026
MBNE vs ESGD side by side
| MBNE | ESGD | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | iShares |
| Category | Municipal Bond | International Stock |
| Expense ratio | 0.43% | 0.2% |
| Annual cost per $10k | $43 | $20 |
| 10-yr cost on $10k (prospectus) | $542 | $255 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +1.7% | +3.8% |
| 5-yr return (annualized) | — | +4.8% |
| 10-yr return (annualized) | — | — |
| Best quarter | +6.8% | +18.0% |
| Worst quarter | −2.9% | −22.4% |
| Net assets (fund) | — | $11.7B |
| Number of holdings | — | 377 |
| Portfolio turnover | 39% | 26% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MBNE | ESGD | Difference |
|---|---|---|---|
| 2024 | +1.7% | +3.8% | −2.1% |
| 2023 | +5.7% | +18.1% | −12.4% |
Source: Fund prospectus bar charts
Holdings overlap
MBNE and ESGD share none of their top holdings.
MBNE top 10
ESGD top 10
- ASML Holding N.V. — 3.11%
- Novartis AG — 1.58%
- Hsbc Holdings Plc — 1.38%
- Siemens Aktiengesellschaft — 1.24%
- Roche Holding AG — 1.20%
- Nestle S.A. — 1.13%
- ABB Ltd — 1.13%
- Astrazeneca Plc — 1.10%
- Sap Se — 1.03%
- Schneider Electric Se — 1.00%
FAQ
What is the difference between MBNE and ESGD?
MBNE (State Street(R) Nuveen Municipal Bond ESG ETF) and ESGD (iShares ESG Aware MSCI EAFE ETF) are both etfs. ESGD is cheaper at 0.2% vs 0.43% — a difference of $23 a year per $10,000 invested.
Which is cheaper, MBNE or ESGD?
ESGD has the lower expense ratio (0.2%).
Should I own both MBNE and ESGD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.